Cell-Free RNA Analysis Agent
The Cell-Free RNA Analysis Agent provides comprehensive analysis of circulating cell-free RNA (cfRNA) from plasma and other biofluids for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.
When to Use This Skill
- When analyzing plasma cfRNA for cancer detection and monitoring.
- To identify tissue-of-origin from circulating transcripts.
- For non-invasive transcriptomic profiling of tumors.
- When integrating cfRNA with cfDNA for comprehensive liquid biopsy.
- To discover RNA-based biomarkers from accessible biofluids.
Core Capabilities
cfRNA Profiling: Quantify mRNA, lncRNA, and small RNA from plasma.
Tissue Deconvolution: Identify tissue sources contributing to cfRNA pool.
Cancer Detection: ML models detecting cancer from cfRNA profiles.
Tumor Transcriptomics: Infer tumor gene expression non-invasively.
Integration with cfDNA: Combine RNA and DNA liquid biopsy analytes.
Biomarker Discovery: Identify diagnostic and prognostic RNA markers.
cfRNA Biology
Sources:
- Cell death (apoptosis, necrosis)
- Active secretion (EVs, RNA-binding proteins)
- Cell surface-associated RNA
Protection Mechanisms:
- Extracellular vesicles
- Protein complexes (AGO2, NPM1)
- Lipoproteins
Half-life: Minutes to hours (shorter than cfDNA)
Workflow
Input: Plasma cfRNA sequencing data (total RNA, small RNA, or targeted).
Quality Control: Assess library complexity, mapping rates, contamination.
Quantification: Normalize and quantify transcripts.
Deconvolution: Estimate tissue contributions.
Classification: Apply cancer detection models.
Integration: Combine with cfDNA if available.
Output: Tissue composition, cancer score, biomarker profiles.
Example Usage
User: "Analyze plasma cfRNA to detect cancer and identify tissue of origin."
Agent Action:
python3 Skills/Genomics/CellFree_RNA_Agent/cfrna_analyzer.py \
--input plasma_cfrna.fastq.gz \
--protocol total_rna \
--reference gencode_v44 \
--deconvolution true \
--cancer_detection true \
--output cfrna_results/
Tissue Deconvolution
Reference Transcriptomes:
- GTEx tissue expression atlas
- Single-cell reference atlases
- Tissue-specific marker genes
Methods:
- Non-negative least squares
- Support vector regression
- Deep learning deconvolution
Clinical Applications:
- Organ injury detection (liver, heart, brain)
- Tumor burden estimation
- Post-transplant monitoring
Cancer Detection Applications
| Cancer Type |
Key Markers |
Performance |
| Lung |
XIST, MALAT1, specific mRNAs |
AUC 0.80-0.90 |
| Breast |
HER2, ER/PR transcripts |
Monitoring |
| Colorectal |
KRAS, panel genes |
Early detection |
| Prostate |
PCA3, TMPRSS2-ERG |
Established |
| Liver |
AFP, specific ncRNAs |
HCC surveillance |
Technical Considerations
Pre-analytical Factors:
- Sample collection (EDTA, cell stabilization)
- Processing time (<4 hours recommended)
- Storage temperature (-80°C)
- Hemolysis avoidance (critical)
Library Preparation:
- Total RNA (captures mRNA, lncRNA)
- Small RNA (miRNA, piRNA)
- Targeted panels (specific genes)
- UMI-based for quantification
AI/ML Components
Cancer Classifier:
- Gradient boosting on gene panels
- Neural networks for full transcriptome
- Multi-cancer detection models
Tissue Predictor:
- Reference-based deconvolution
- Supervised tissue classifiers
- Anomaly detection for novel sources
Integration with Other Analytes
| Analyte |
Strength |
Combination Benefit |
| cfDNA |
Mutations, methylation |
Genomic + transcriptomic |
| CTCs |
Single-cell analysis |
Cellular confirmation |
| Exosomes |
Protected RNA |
Source identification |
| Proteins |
Functional markers |
Multi-modal biomarkers |
Prerequisites
- Python 3.10+
- STAR/Salmon for alignment
- DESeq2/edgeR for quantification
- Tissue deconvolution tools
Related Skills
- Liquid_Biopsy_Analytics_Agent - For comprehensive liquid biopsy
- Exosome_EV_Analysis_Agent - For EV-derived RNA
- ctDNA_Analysis - For DNA-based markers
Emerging Technologies
- Targeted cfRNA: Gene panels for specific cancers
- Single-molecule: Direct RNA sequencing
- Spatial deconvolution: Mapping cfRNA to tissue regions
- Longitudinal monitoring: Treatment response tracking
Author
AI Group - Biomedical AI Platform
1---2name: cellfree-rna-agent3description: AI-powered cell-free RNA analysis from liquid biopsy for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.4---56<!--7# COPYRIGHT NOTICE8# This file is part of the "Universal Biomedical Skills" project.9# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>10# All Rights Reserved.11#12# This code is proprietary and confidential.13# Unauthorized copying of this file, via any medium is strictly prohibited.14#15# Provenance: Authenticated by MD BABU MIA1617-->18192021# Cell-Free RNA Analysis Agent2223The **Cell-Free RNA Analysis Agent** provides comprehensive analysis of circulating cell-free RNA (cfRNA) from plasma and other biofluids for cancer detection, tissue-of-origin identification, and non-invasive transcriptomic profiling.2425## When to Use This Skill2627* When analyzing plasma cfRNA for cancer detection and monitoring.28* To identify tissue-of-origin from circulating transcripts.29* For non-invasive transcriptomic profiling of tumors.30* When integrating cfRNA with cfDNA for comprehensive liquid biopsy.31* To discover RNA-based biomarkers from accessible biofluids.3233## Core Capabilities34351. **cfRNA Profiling**: Quantify mRNA, lncRNA, and small RNA from plasma.36372. **Tissue Deconvolution**: Identify tissue sources contributing to cfRNA pool.38393. **Cancer Detection**: ML models detecting cancer from cfRNA profiles.40414. **Tumor Transcriptomics**: Infer tumor gene expression non-invasively.42435. **Integration with cfDNA**: Combine RNA and DNA liquid biopsy analytes.44456. **Biomarker Discovery**: Identify diagnostic and prognostic RNA markers.4647## cfRNA Biology4849**Sources**:50- Cell death (apoptosis, necrosis)51- Active secretion (EVs, RNA-binding proteins)52- Cell surface-associated RNA5354**Protection Mechanisms**:55- Extracellular vesicles56- Protein complexes (AGO2, NPM1)57- Lipoproteins5859**Half-life**: Minutes to hours (shorter than cfDNA)6061## Workflow62631. **Input**: Plasma cfRNA sequencing data (total RNA, small RNA, or targeted).64652. **Quality Control**: Assess library complexity, mapping rates, contamination.66673. **Quantification**: Normalize and quantify transcripts.68694. **Deconvolution**: Estimate tissue contributions.70715. **Classification**: Apply cancer detection models.72736. **Integration**: Combine with cfDNA if available.74757. **Output**: Tissue composition, cancer score, biomarker profiles.7677## Example Usage7879**User**: "Analyze plasma cfRNA to detect cancer and identify tissue of origin."8081**Agent Action**:82```bash83python3 Skills/Genomics/CellFree_RNA_Agent/cfrna_analyzer.py \84 --input plasma_cfrna.fastq.gz \85 --protocol total_rna \86 --reference gencode_v44 \87 --deconvolution true \88 --cancer_detection true \89 --output cfrna_results/90```9192## Tissue Deconvolution9394**Reference Transcriptomes**:95- GTEx tissue expression atlas96- Single-cell reference atlases97- Tissue-specific marker genes9899**Methods**:100- Non-negative least squares101- Support vector regression102- Deep learning deconvolution103104**Clinical Applications**:105- Organ injury detection (liver, heart, brain)106- Tumor burden estimation107- Post-transplant monitoring108109## Cancer Detection Applications110111| Cancer Type | Key Markers | Performance |112|-------------|-------------|-------------|113| Lung | XIST, MALAT1, specific mRNAs | AUC 0.80-0.90 |114| Breast | HER2, ER/PR transcripts | Monitoring |115| Colorectal | KRAS, panel genes | Early detection |116| Prostate | PCA3, TMPRSS2-ERG | Established |117| Liver | AFP, specific ncRNAs | HCC surveillance |118119## Technical Considerations120121**Pre-analytical Factors**:122- Sample collection (EDTA, cell stabilization)123- Processing time (<4 hours recommended)124- Storage temperature (-80°C)125- Hemolysis avoidance (critical)126127**Library Preparation**:128- Total RNA (captures mRNA, lncRNA)129- Small RNA (miRNA, piRNA)130- Targeted panels (specific genes)131- UMI-based for quantification132133## AI/ML Components134135**Cancer Classifier**:136- Gradient boosting on gene panels137- Neural networks for full transcriptome138- Multi-cancer detection models139140**Tissue Predictor**:141- Reference-based deconvolution142- Supervised tissue classifiers143- Anomaly detection for novel sources144145## Integration with Other Analytes146147| Analyte | Strength | Combination Benefit |148|---------|----------|---------------------|149| cfDNA | Mutations, methylation | Genomic + transcriptomic |150| CTCs | Single-cell analysis | Cellular confirmation |151| Exosomes | Protected RNA | Source identification |152| Proteins | Functional markers | Multi-modal biomarkers |153154## Prerequisites155156* Python 3.10+157* STAR/Salmon for alignment158* DESeq2/edgeR for quantification159* Tissue deconvolution tools160161## Related Skills162163* Liquid_Biopsy_Analytics_Agent - For comprehensive liquid biopsy164* Exosome_EV_Analysis_Agent - For EV-derived RNA165* ctDNA_Analysis - For DNA-based markers166167## Emerging Technologies1681691. **Targeted cfRNA**: Gene panels for specific cancers1702. **Single-molecule**: Direct RNA sequencing1713. **Spatial deconvolution**: Mapping cfRNA to tissue regions1724. **Longitudinal monitoring**: Treatment response tracking173174## Author175176AI Group - Biomedical AI Platform177178179<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->